Strides Arcolab gains despite reporting 93% fall in Q3 net profit

14 Nov 2013 Evaluate

Strides Arcolab is currently trading at Rs. 922.00, up by 9.75 points or 1.07 % from its previous closing of Rs. 912.25 on the BSE.

The scrip opened at Rs. 914.00 and has touched a high and low of Rs. 933.30 and Rs. 906.00 respectively. So far 71737 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 552.65 on 01-Aug-2013.

Last one week high and low of the scrip stood at Rs. 928.75 and Rs. 886.75 respectively. The current market cap of the company is Rs. 5428.17 crore.

The promoters holding in the company stood at 27.36% while Institutions and Non-Institutions held 58.54% and 14.11% respectively.

Strides Arcolab has reported 92.66% fall in its net profit at Rs 2.21 crore for third quarter ended September 30, 2013 as compared to Rs 30.11 crore for the same quarter in the previous year. However, total income of the company has increased by 13.59% at Rs 225.46 crore for quarter under review as compared to Rs 198.48 crore for the quarter ended September 30, 2012.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×